Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Tvardi To Contact Him Directly To Discuss Their Options If you suffered significant losses in Tvardi stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or […]
(NASDAQ:BEAM), CAMBRIDGE, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer of Beam, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 5:15 p.m. PT in San
(Brussels:GLPG),(Euronext Amsterdam:GLPG), GLPG3667 met primary endpoint in dermatomyositis study, demonstrating a statistically significant clinical benefit and meaningful improvements on secondary measures of disease activity compared to placebo In the systemic lupus erythematosus study, GLPG3667 delivered numerical improvements on several secondary endpoints compared to placebo but did not achieve statistical significance in primary endpoint analysis The
Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus GlobeNewswire December 18, 2025 GLPG3667 met primary endpoint in dermatomyositis study, demonstrating a statistically significant clinical benefit and meaningful improvements on secondary measures of disease activity compared to placebo In the systemic lupus erythematosus study,
Beam Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire December 18, 2025 CAMBRIDGE, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer of Beam, will present at the 44th Annual J.P.
Stanley Black & Decker(NYSE: SWK)will broadcast its fourth quarter and full year 2025 earnings webcast on Wednesday, February 4, 2026. The webcast will begin at 8:00AM ET. A news release outlining the financial results will be distributed before the market opens on Wednesday, February 4, 2026. A slide presentation which will accompany the call will
LEIFRAS Co., Ltd. (Nasdaq: LFS) (the “Company” or “Leifras”), a sports and social business company dedicated to youth sports and community engagement,today announced its unaudited financial results for the nine months ended September 30, 2025. Financial Highlights for the NineMonths Ended September30, 2025 — Revenuewas JPY8.6billion ($57.8million) for the nine months ended September 30, 2025,
(NASDAQ:DCX), New York, Dec. 18, 2025 (GLOBE NEWSWIRE) — Digital Currency X Technology Inc. (NASDAQ: DCX) (“DCX” or the “Company”) today announced that it received a letter from The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that it is currently not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires the Company to maintain
Digital Currency X Technology Inc. Announces Receipt of Nasdaq Notification Regarding Market Value of Listed Securities Requirement GlobeNewswire December 18, 2025 New York, Dec. 18, 2025 (GLOBE NEWSWIRE) — Digital Currency X Technology Inc. (NASDAQ: DCX) (“DCX” or the “Company”) today announced that it received a letter from The Nasdaq Stock Market LLC (“Nasdaq”), notifying
American Legion National Commander Dan K. Wiley stood alongside President Donald Trump in the Oval Office Thursday when the president issued an executive order to reclassify cannabis in a way that will allow FDA to legally conduct research into its therapeutic value for veterans. https://mma.prnewswire.com/media/841525/American_Legion_Logo.jpg “This is a really important executive order, and The American